送出
Products
Reproductive Medicine
Prenatal Testing
Chromosomal Microarray Analysis of Amniotic Fluid (Cyto-500+)
Chromosomal Microarray Analysis of Amniotic Fluid (Cyto-80+)
Chromosomal Microarray Analysis for Miscarriage
Newborn Screening
Sensorineural Hearing Loss Screening
Congenital Cytomegalovirus(CMV) Infection Screening
Congenital Central Hypoventilation Syndrome(CCHS) Screening
Pediatrics Genetic Testing
Pediatric Array CGH Analysis ( Cyto–500+ )
Baby Growth and Development Genetic Testing (Cyto-80+)
Whole Exome Sequencing for DD/ID
Breastfeeding Genetic Testing
Oncology
Endometrial Cancer - Mpap Test
Liver Cancer - ctDNA Methylation Test
Population Medicine
Translational Medicine
Scientific Research Services
MicroArray Services Overview
Next Generation Sequencing Services
Bioinformatics
Custom Microarray Design & Printing Services
OneArray® Products
qPCR Services
Health Education
Health Education Info
Mother's Testimony
News
Phalanx Biotech Events
Media Reports
Q&A
Amniotic Fluid Microarray
Non-Invasive Prenatal Tests
Tumor Genetic Testing
Prenatal DNA Paternity Test
Population Medicine
About US
Introduction
Company Video
Quality Assurance
Central Laboratory
Recruitment
Contact Us
Facebook
INSTAGRAM
Line
YOUTUBE
English
繁體中文
English
線上諮詢
English
繁體中文
English
scroll down
Search
×
Inquiry
LINE
phalanx biotech
Media Interviews
Home
Video
Media Interviews
phalanx biotech
Media Interviews
癌症術後治療有「選對」用藥？華聯直接找到突變的基因對症下藥！
肝癌術後追蹤現曙光！台大消融術後：發現ctDNA甲基化有望更精準監控早期復發
產前檢查怎麼選？一次瞭解羊水晶片、核型分析的差異｜華聯生技說
【媒體專訪】 Discovery (Health Heroes)專訪亞洲生技之星 - 華聯生技
【媒體專訪】環宇電台【創新100】專訪 - 華聯生技
【媒體專訪】大愛電視台專訪 - 華聯生技
